fimbrial
vaccin
routin
given
parenter
pregnant
cattl
sheep
swine
protect
suckl
newborn
calv
lamb
pig
enterotoxigen
escherichia
coli
etec
infect
vaccin
practic
effect
fatal
etec
infect
farm
anim
occur
earli
neonat
period
antibodi
titr
colostrum
milk
highest
etec
farm
anim
belong
small
famili
fimbrial
antigen
type
fimbria
consist
good
protein
antigen
bacteri
surfac
readili
access
antibodi
fimbria
requiredjor
critic
step
adhesioncolon
earl
pathogenesi
diseas
etec
infect
continu
signific
clinic
problem
farm
anim
spite
extens
use
fimbriaebas
vaccin
definit
data
efficaci
commerci
vaccin
infield
use
avail
prevail
percept
among
anim
health
profession
vaccin
effect
problem
occur
chiefli
among
nonvaccin
anim
herd
vaccin
move
peak
preval
diseas
first
second
third
week
birth
mortal
lower
suggest
extens
use
vaccin
rapidli
select
emerg
novel
previous
low
preval
fimbrial
antigen
type
evid
happen
decad
routin
vaccin
use
unit
state
howev
activ
direct
surveil
emerg
contrast
ration
develop
vaccin
provid
passiv
lacteal
protect
etec
suckl
neonat
compar
littl
progress
made
provid
knowledg
requir
develop
vaccin
protect
qainst
etec
infect
swine
research
conduct
anim
human
health
laboratori
around
world
establish
rational
vaccin
control
enterotoxigen
escherichia
coli
etec
infect
neonat
farm
anim
comprehens
review
research
avail
research
confirm
longheld
hypothesi
certain
strain
e
coli
caus
diarrhoeal
diseas
colibacillosi
occur
commonli
among
neonat
calv
pig
establish
concept
pathogenesi
diarrhoea
caus
etec
similar
human
cholera
bacteria
adher
small
intestin
epithelium
stimul
local
secret
electrolyt
water
e
coli
enterotoxin
specif
type
fimbria
pili
requir
virul
attribut
etec
act
respect
intestin
secretagogu
adhesin
colon
factor
host
speci
specif
etec
depend
larg
ligand
receptor
fit
among
variou
type
offimbria
receptor
intestin
epitheli
cell
host
etec
associ
diseas
anim
belong
small
famili
fimbria
enterotoxin
type
fatal
etec
infect
farm
anim
occur
earli
neonat
suckl
period
neonat
suckl
dam
vaccin
etec
fimbria
protect
challeng
etec
bear
fimbrial
antigen
homolog
vaccin
strain
gener
accept
concept
led
commerci
develop
fimbria
base
vaccin
control
etec
infect
farm
anim
vaccin
design
parenter
administr
pregnant
dam
increas
content
fimbrial
antibodi
colostrum
milk
suckl
establish
maintain
level
fimbrial
antibodi
small
intestin
prevent
intens
colon
etec
highli
suscept
neonat
period
first
fimbriaebas
etec
vaccin
bacterin
commerci
use
us
livestock
licens
unit
state
depart
agricultur
usda
vaccin
bacterin
routin
use
us
ten
year
describ
aspect
use
etec
vaccin
us
also
attempt
assess
impact
decad
routin
use
fimbria
base
vaccin
diseas
us
data
usda
licens
biolog
produc
prevent
e
coli
infect
livestock
summar
tabl
distinct
commerci
vaccin
bacterin
produc
parenter
vaccin
pregnant
cattl
sheep
swine
vaccin
use
cattl
includ
fimbrial
antigen
swine
includ
twentyon
vaccin
also
includ
least
one
includ
type
pili
fimbrial
antigen
addit
fimbrial
antigen
one
swine
product
vaccin
includ
label
claim
heat
labil
enterotoxin
base
b
subunit
lt
toxin
use
antigen
four
vaccin
produc
e
coli
strain
contain
plasmid
construct
via
recombin
dna
technolog
mani
product
design
protect
diseas
addit
etec
infect
therefor
addit
etec
fimbrial
antigen
twothird
vaccin
produc
also
contain
antigen
pathogen
pasteurella
sp
bordetella
sp
clostridium
sp
rotaviru
coronaviru
product
design
parenter
vaccin
two
dose
first
pregnanc
singl
booster
succeed
pregnanc
million
dose
produc
use
swine
produc
cattl
minor
use
sheep
estim
inventori
livestock
us
farm
million
femal
breed
swine
million
breed
cow
million
dairi
million
beef
breed
femal
swine
farrow
twice
year
remain
breed
herd
year
cow
calv
year
remain
breed
herd
five
year
longer
thu
satur
use
vaccin
us
swine
cattl
breed
herd
would
probabl
requir
annual
product
million
dose
respect
assum
vaccin
produc
us
use
domest
export
amount
known
number
dose
producedyear
approxim
number
dose
usedyear
us
anim
inventori
data
combin
vaccin
product
data
tabl
indic
vaccin
use
much
intens
swine
cattl
intens
use
pregnant
swine
confirm
recent
survey
us
swine
produc
report
routin
use
e
coli
vaccin
preval
sever
clinic
etec
infect
greatest
intens
manag
system
close
confin
larg
number
anim
beef
cow
us
manag
extens
intens
manag
system
common
dairi
swine
product
thu
think
vaccin
probabl
use
greater
proport
dairi
beef
cow
recommend
vaccin
use
strateg
rather
univers
cattl
cost
benefit
ratio
achiev
studi
econom
aspect
strateg
use
addit
vaccin
nearli
million
dose
e
coli
antiserum
produc
tabl
product
design
oral
parenter
administr
newborn
calv
lamb
piglet
foal
product
design
protect
e
coli
bacteraemia
septicaemia
hypogammaglobulinaem
neonat
hypogammaglobulinaemia
common
normal
passiv
ig
transfer
utero
transfer
farm
ranch
condit
frequent
inadequ
sever
oral
administ
product
contain
antibodi
fimbria
design
prevent
etec
infect
approach
ration
high
proport
fatal
etec
infect
occur
first
day
birth
particularli
calv
nearli
calf
etec
produc
fimbria
calv
suscept
colon
etec
first
one
two
day
birth
thu
hour
local
protect
deliv
intestin
singl
oral
dose
monoclon
antibodi
provid
effect
protect
efficaci
vaccin
dam
fimbria
protect
suckl
neonat
etec
infect
via
passiv
lacteal
immun
first
convincingli
demonstr
rutter
jone
use
fimbria
swine
subsequ
work
confirm
efficaci
approach
gener
concept
extend
etec
fimbria
anim
speci
also
demonstr
etec
fimbria
appar
crossprotect
epitop
therefor
vaccin
use
contain
fimbrial
antigen
preval
target
host
speci
vaccin
current
use
probabl
achiev
includ
vaccin
cattl
combin
pregnant
swine
although
fimbria
preval
among
anim
etec
efficaci
protect
antigen
vaccin
cattl
swine
less
well
defin
anim
etec
produc
also
produc
vaccin
dam
protect
calv
pig
etec
strain
bear
seri
experi
util
challeng
strain
etec
strain
produc
three
fimbria
fi
vaccin
found
strain
produc
fi
small
intestin
pig
diseas
vaccin
protect
challeng
strain
vaccin
either
howev
vaccin
protect
piglet
challeng
etec
strain
vaccin
appar
effect
vaccin
protect
mice
etec
controversi
role
f
fimbria
pathogenesi
etec
infect
efficaci
protect
antigen
vaccin
prevent
diseas
discuss
convinc
evid
vaccin
pregnant
swine
antigen
direct
heat
labil
enterotoxin
procholeragenoid
lth
protect
piglet
born
suckl
vaccin
challeng
lt
etec
princip
barrier
gener
develop
antitox
vaccin
fact
mani
porcin
etec
strain
produc
one
heat
stabl
e
coli
enterotoxin
sta
stb
addit
instead
lt
bovin
etec
produc
sta
contrast
lt
neither
stb
sta
antigen
rapidli
excret
bacteri
cell
rather
concentr
near
bacteri
surfac
periplasm
space
like
lt
furthermor
sta
effect
protect
antigen
use
hapten
vaccin
stimul
product
sta
neutral
antitoxin
porcin
etec
produc
lt
also
produc
stb
vaccin
procholeragenoid
ltn
protect
lt
stb
etec
mechan
lt
induc
protect
antigen
unrel
stb
enterotoxin
defin
could
resid
appar
antibacteri
anticolon
effect
lt
vaccin
vaccin
includ
polysaccharid
cell
wall
k
capsular
antigen
repres
common
among
porcin
bovin
etec
conflict
evid
regard
efficaci
antigen
base
vaccin
one
seri
experi
antigen
effect
true
capsular
polysaccharid
k
antigen
mucoid
heat
stabl
varieti
appear
effect
regardless
efficaci
practic
valu
polysaccharid
k
antigen
limit
multipl
k
antigen
commonli
occur
among
etec
ie
vaccin
reason
limit
valenc
would
expect
provid
broad
efficaci
furthermor
mani
etec
lack
true
polysaccharid
varieti
capsul
usda
licensur
polici
recogn
proprietari
natur
efficaci
data
specif
commerci
product
public
data
relat
vaccin
licens
us
requir
field
trial
indic
efficaci
fimbria
base
vaccin
swine
lack
efficaci
combin
rotaviru
coronaviru
vaccin
dairi
cattl
publish
field
trial
data
demonstr
efficaci
product
commerci
use
us
avail
usda
receiv
investig
consum
report
concern
safeti
efficaci
licens
vaccin
commerci
use
total
report
receiv
usda
anim
plant
health
inspect
servic
veterinari
biolog
field
oper
product
type
list
tabl
period
octob
januari
five
report
concern
efficaci
assum
complaint
direct
enterotoxigen
e
coli
infect
hw
moon
bunn
manufactur
rather
usda
total
number
complaint
receiv
much
higher
report
usda
nevertheless
low
number
report
receiv
usda
eight
year
use
consist
anecdot
report
well
prevail
opinion
anim
health
profession
livestock
produc
vaccin
effect
commerci
use
data
indic
incid
morbid
mortal
due
etec
infect
chang
sinc
introduct
commerci
vaccin
avail
nation
survey
us
swine
health
found
pigslitt
piglet
born
aliv
period
decemb
januari
die
reach
one
month
age
tm
diarrhoea
report
common
ill
observ
nearli
death
first
month
birth
attribut
diarrhoea
tabl
fortyseven
per
cent
produc
survey
report
routin
vaccin
dam
prevent
etec
infect
piglet
tabl
determin
percentag
ill
death
attribut
diarrhoea
herd
report
routin
vaccin
differ
nation
survey
data
cattl
health
us
yet
avail
howev
result
veterinari
diagnost
laboratori
also
indic
etec
infect
common
caus
calf
diarrhoea
us
tabl
thu
etec
infect
continu
signific
clinic
problem
among
calv
piglet
us
spite
extens
vaccin
proport
problem
occur
offspr
properli
vaccin
dam
known
prevail
percept
among
anim
health
profession
vaccin
effect
field
diseas
occur
princip
among
nonvaccin
inadequ
vaccin
anim
veterinarian
also
percept
swine
herd
vaccin
move
peak
preval
clinic
diseas
first
second
third
week
birth
therebi
significantli
reduc
mortal
morbid
j
mckean
person
commun
possibl
extend
passiv
protect
beyond
first
week
later
suckl
period
use
oral
vaccin
use
combin
oral
parenter
vaccin
ration
hypothes
extens
use
fimbrial
base
vaccin
select
prevail
fimbrial
antigen
type
reflect
vaccin
emerg
new
previous
low
preval
fimbrial
antigen
fimbria
antigen
distinct
occur
among
anim
etec
antigen
type
appar
less
preval
current
use
commerci
vaccin
role
fimbria
pathogenesi
less
well
defin
fvariant
etec
frequent
emerg
cours
etec
infect
anim
appar
result
select
pressur
exert
antibodi
suggest
extens
vaccin
may
caus
emerg
etec
ad
variant
among
swine
europ
argument
hypothesi
vaccin
induc
select
pressur
reason
emerg
etec
european
swine
present
wilson
franci
found
etec
collect
us
piglet
account
probabl
accur
reflect
preval
three
fimbrial
antigen
among
porcin
etec
us
prior
extens
use
commerci
vaccin
three
fimbrial
antigen
continu
commonli
associ
etec
infect
among
us
piglet
exampl
depart
veterinari
diagnost
investig
univers
minnesota
diagnos
swine
access
one
sever
pig
examinedaccess
etec
infect
period
report
posit
immunofluoresc
test
three
fimbrial
antigen
among
access
eightyf
per
cent
posit
test
ratio
plu
wilson
franci
report
compar
minnesota
report
specul
appar
shift
etec
somehow
reflect
vaccin
suggest
sinc
advent
vaccin
etec
infect
control
effect
due
etec
may
reflect
shift
peak
diseas
preval
first
second
third
fourth
week
birth
etec
caus
diseas
age
span
etec
infect
confin
princip
first
day
age
vaccin
induc
milk
colostr
antibodi
titr
highest
vaccin
would
expect
effect
age
shift
would
consist
percept
us
veterinarian
cite
earlier
effect
extens
use
vaccin
europ
report
et
al
decad
ago
data
indic
whether
appar
shift
preval
due
decreas
incid
diseas
first
week
birth
increas
incid
diseas
second
later
week
high
preval
etec
infect
could
also
reflect
emerg
antigen
variant
suggest
occur
europ
awar
recent
data
preval
porcin
etec
produc
would
expect
vaccin
induc
select
pressur
increas
preval
report
wilson
franci
etec
vaccin
develop
anim
focus
problem
occur
earli
neonat
period
first
week
birth
howev
swine
high
incid
etec
infect
also
occur
immedi
wean
us
piglet
usual
wean
week
age
trend
toward
wean
week
age
mortal
rate
among
affect
pig
lower
postwean
diseas
neonat
diseas
pathogenesi
postwean
diseas
similar
neonat
diseas
fimbria
enterotoxin
requir
virul
attribut
associ
etec
howev
postwean
diseas
appear
complex
multipl
factor
predispos
caus
clinic
diseas
appar
predispos
caus
social
physic
stress
diet
increas
gastric
ph
concurr
rotaviru
infect
cessat
local
protect
provid
antibodi
ingest
milk
suckl
costeffect
control
diseas
centr
around
hygien
manag
minim
predispos
caus
antimicrobi
drug
commonli
use
prophylact
therapeut
logic
extend
concept
fimbrial
vaccin
includ
postwean
etec
infect
commerci
vaccin
prepar
kill
strain
etec
isol
postwean
diseas
avail
us
one
product
design
parenter
administr
piglet
prior
wean
design
fed
sever
week
suckl
immedi
postwean
period
data
support
rational
efficaci
vaccin
limit
st
parenter
vaccin
tend
stimul
system
rather
mucos
immun
system
inadequ
deliveri
system
produc
igg
blood
intestin
lumen
limit
efficaci
parent
vaccin
etec
agent
remain
lumen
intestin
epitheli
surfac
oral
vaccin
stimul
mucos
immun
system
produc
secretori
antibodi
effici
transport
intestin
lumen
live
etec
effect
oral
fimbrial
vaccin
kill
etec
gener
less
effect
ss
recent
effort
focus
develop
live
oral
fimbrial
base
vaccin
prevent
postwean
etec
infect
swine
vaccin
would
ideal
temporarili
colon
small
intestin
suckl
pig
spite
antifimbri
antibodi
ingest
milk
produc
enterotoxin
substanc
would
advers
affect
health
product
colon
piglet
stimul
mucos
immun
system
pig
secret
protect
level
antifimbri
iga
small
intestin
reflect
fimbrial
antigen
preval
among
etec
associ
postwean
diarrhoea
fimbriai
antigen
etec
associ
postwean
diarrhoea
swine
differ
somewhat
associ
diseas
neonat
pig
physiolog
resist
colon
etec
week
age
thu
strain
commonli
associ
postwean
diseas
age
resist
etec
appear
due
least
part
decreas
avail
age
receptor
epitheli
cell
hand
resist
correl
increas
avail
receptor
mucu
receptor
mucu
appar
prevent
contact
etec
receptor
epitheli
surfac
recept
swine
intestin
mucu
also
increas
age
howev
increas
adequ
protect
genet
suscept
pig
colon
etec
associ
diseas
neonat
postwean
period
fimbrial
antigen
associ
postwean
etec
infect
well
defin
seem
like
addit
yet
unrecogn
fimbrial
antigen
type
preval
age
suggest
evid
first
three
week
birth
swine
intestin
becom
progress
recept
adhes
colon
etec
unrecogn
fimbrial
antigen
type
pattern
emerg
variat
avail
receptor
fimbria
affect
etec
infect
sever
differ
way
inherit
trait
express
fimbrial
receptor
intestin
epitheli
cell
autosom
domin
charact
swine
homozyg
recess
genotyp
lack
requir
specif
receptor
resist
etec
neonat
postwean
period
variat
receptor
phenotyp
exist
correl
antigen
variat
among
fimbria
suggest
select
pressur
exert
variat
receptor
avail
may
altern
exert
antibodi
evolut
antigen
variant
fimbria
genet
control
receptor
express
may
also
influenc
resist
e
coli
yet
unrecogn
fimbrial
antigen
type
associ
postwean
diseas
swine
hand
chang
age
avail
distribut
receptor
appar
determin
suscept
resist
etec
exampl
avail
epitheli
cell
receptor
decreas
age
avail
postwean
etec
increas
vaccin
given
pregnant
femal
produc
antifimbri
antibodi
colostrum
milk
lacteal
antibodi
passiv
protect
intestin
suckl
neonat
colon
etec
highli
suscept
earli
neonat
period
data
efficaci
commerci
vaccin
decad
routin
use
avail
continu
gener
regard
effect
howev
etec
infect
continu
common
problem
among
neonat
calv
pig
us
data
indic
whether
problem
occur
princip
among
anim
suckl
vaccin
nonvaccin
dam
avail
unpublish
anecdot
report
swine
herd
vaccin
move
peak
incid
morbid
first
second
third
week
birth
high
ratio
compar
etec
infect
among
swine
submit
diagnost
laboratori
consist
anecdot
report
piglet
physiolog
suscept
etec
first
week
birth
evid
etec
novel
colon
mechan
new
fimbrial
antigen
emerg
select
pressur
vaccin
evid
previous
low
preval
fimbrial
antigen
type
etec
repres
vaccin
emerg
common
pathogen
fill
ecolog
nich
left
fimbrial
antigen
type
target
vaccin
admittedli
appar
activ
direct
surveil
event
event
could
explain
continu
common
occurr
neonat
etec
infect
among
swine
face
intens
vaccin
seem
unlik
howev
event
could
account
high
incid
diseas
go
unrecogn
fimbrial
antigen
test
routin
use
laboratori
confirm
etec
infect
high
incid
diseas
caus
etec
would
like
recogn
report
knowledg
technolog
gener
develop
fimbrial
vaccin
control
postwean
etec
infect
swine
yet
avail
fimbrial
antigen
etec
preval
age
well
defin
immunolog
approach
establish
maintain
protect
level
ofantifimbri
antibodi
small
intestin
pig
first
week
wean
develop
compar
medic
perspect
experiment
studi
farm
anim
demonstr
fimbrial
vaccin
protect
etec
infect
practic
costeffect
use
anim
possibl
anim
suscept
diseas
first
day
birth
intestin
suckl
anim
protect
colostrum
milk
antibodi
produc
vaccin
dam
strategi
gener
commerci
extens
concept
beyond
passiv
lacteal
immun
earli
neonat
period
anim
yet
develop
task
extend
concept
human
protect
need
nurs
period
also
wean
throughout
childhood
clearli
much
greater
ration
challeng
